Inventor
FROESTL WOLFGANG
31 patents
⚠️ This page may combine multiple inventors who share the name “FROESTL WOLFGANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CIBA GEIGY CORP
19 patentsUS5407922AApr 18, 1995
Certain N-substituted-amino-alkane phosphinic acid derivatives having anti-epileptic properties
CIBA GEIGY CORP52 citations94
US5229379AJul 20, 1993
Certain n-substituted-amino-alkane phosphinic acid derivatives having anti-epileptic properties
CIBA GEIGY CORP64 citations94
US5461040AOct 24, 1995
Substituted aminoalkylphosphinic acids
CIBA GEIGY CORP24 citations92
US5332729AJul 26, 1994
N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids
CIBA GEIGY CORP29 citations92
US5300679AApr 5, 1994
Substituted propane-phosphinic acid compounds
CIBA GEIGY CORP29 citations92
US5281747AJan 25, 1994
Substituted aminoalkylphosphinic acids
CIBA GEIGY CORP27 citations92
US5190933AMar 2, 1993
Substituted propane-phosphinic acid compounds
CIBA GEIGY CORP24 citations92
US5051524ASep 24, 1991
Substituted propane-phosphinic acid compounds
CIBA GEIGY CORP29 citations92
US4614614ASep 30, 1986
Process for the manufacture of optically active azetidinones
CIBA GEIGY CORP50 citations92
US5064819ANov 12, 1991
Substituted propane-phosphinic acid compounds
CIBA GEIGY CORP16 citations81
US4957928ASep 18, 1990
Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds
CIBA GEIGY CORP17 citations80
US5424441AJun 13, 1995
N-aralkyl-and N-heteroaralkyl-aminoalkanephosphinic acids
CIBA GEIGY CORP15 citations74
US5112855AMay 12, 1992
Hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds and compositions
CIBA GEIGY CORP7 citations72
US5204342AApr 20, 1993
Saturated tetracyclic nitrogen heterocycles
CIBA GEIGY CORP3 citations59
US5135930AAug 4, 1992
Hydrogenated nitrogen containing tetracycles having two nonadjacent lactam rings
CIBA GEIGY CORP2 citations59
US4833169AMay 23, 1989
Hydropyridine derivatives
CIBA GEIGY CORP2 citations59
US5204334AApr 20, 1993
Benzoheterocyclylalkylaminoalkanediphosphonic acids, compositions thereof, and use thereof in the treatment of calcium metabolism disorders
CIBA GEIGY CORP0 citations52
US4939160AJul 3, 1990
Hydropyridine derivatives
CIBA GEIGY CORP1 citations49
US4945092AJul 31, 1990
Substituted 1-(oxopyrrolidinylalkanoyl)-piperazines useful as nootropics
CIBA GEIGY CORP1 citations45
NOVARTIS AG
4 patentsUS7655666B2Feb 2, 2010
Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands
NOVARTIS AG2 citations60
US8012988B2Sep 6, 2011
N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-quinazolin-3-yl)methanesulfonamide
NOVARTIS AG0 citations49
US7119189B2Oct 10, 2006
Metabotropic GABA [B] receptors, receptor-specific ligands and their uses
NOVARTIS AG0 citations46
US7498319B2Mar 3, 2009
Phosphinic acid derivatives
NOVARTIS AG0 citations42
AC IMMUNE SA
3 patentsUS9701660B2Jul 11, 2017
2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
AC IMMUNE SA2 citations72
US10500207B2Dec 10, 2019
Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
AC IMMUNE SA1 citations59
US10662193B2May 26, 2020
Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins
AC IMMUNE SA1 citations56
KROTH HEIKO
2 patentsUS9221812B2Dec 29, 2015
Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
KROTH HEIKO15 citations79
US8916590B2Dec 23, 2014
2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
KROTH HEIKO2 citations61